Trial intelligence / Profile preview

Effect of aminobisphosphonates and simvastatin on circulating Vgamma9Vdelta2 T cells

NL-OMON36478Active, not recruiting

Sponsor
Vrije University Medical Center
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of simvastatin in bone metastases and Non-hematologic malignancy (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Phenotypic and functional changes in circulating Vgamma9Vdelta2 T cells and Febrile response. Started Nov 2010; status: active, not recruiting.

02

Drugs

simvastatin
03

Conditions

bone metastasesNon-hematologic malignancy

Beyond the preview

Go deeper on NL-OMON36478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call